Adverum Biotechnologies
ADVM
ADVM
126 hedge funds and large institutions have $790M invested in Adverum Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 19 closing their positions.
Holders
126
Holders Change
+10
Holders Change %
+8.62%
% of All Funds
2.78%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.15%
New
33
Increased
52
Reduced
30
Closed
19
Calls
$12.2M
Puts
$1.14M
Net Calls
+$11M
Net Calls Change
+$1.19M
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$33.7M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$2.09M |
| 3 |
3
Renaissance Technologies
New York
|
$10.6M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$24.2M |
| 5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$0 |
